DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 078502
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
NDA 078502 describes ELIPHOS, which is a drug marketed by Cypress Pharm and is included in one NDA. Additional details are available on the ELIPHOS profile page.
The generic ingredient in ELIPHOS is calcium acetate. There are two hundred and eighty-two drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.
The generic ingredient in ELIPHOS is calcium acetate. There are two hundred and eighty-two drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.
Summary for 078502
| Tradename: | ELIPHOS |
| Applicant: | Cypress Pharm |
| Ingredient: | calcium acetate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 667MG | ||||
| Approval Date: | Nov 25, 2008 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
